Cystic fibrosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Cystic fibrosis (CF) is caused by mutations in the CFTR gene, leading to defective CFTR protein function. This protein normally regulates chloride and sodium ions across epithelial cell membranes, maintaining fluid balance in various organs.

• Secondary mechanism: The defective CFTR protein results in thick, sticky mucus production, predominantly affecting the lungs and digestive system. This abnormal mucus impairs mucociliary clearance in the airways, increasing susceptibility to chronic respiratory infections and inflammation.

• Key complication: Over time, persistent lung infections and inflammation lead to airway obstruction and progressive lung damage. In the digestive system, thick mucus obstructs pancreatic ducts, hindering enzyme release, causing malabsorption and nutritional deficiencies, crucial for patient management.

Patient Profile

Demographics:

28-year-old female, respiratory therapist

History:

• Key past medical history: Diagnosed with cystic fibrosis at age 3, history of recurrent lung infections, pancreatic insufficiency

• Current medications: Dornase alfa, pancreatic enzyme supplements, azithromycin, inhaled tobramycin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased cough and shortness of breath

• Key symptoms: Persistent productive cough, wheezing, fatigue, weight loss, sinus congestion

• Vital signs: Temperature 100.4°F, heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 110/70 mmHg, oxygen saturation 90% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to conduct a series of diagnostic tests to better understand the patient's current condition and identify any developing complications. A high-resolution CT scan of the chest was performed, revealing areas of bronchiectasis, which are consistent with the patient's history of chronic lung infections. Additionally, new infiltrates were noted in the right middle lobe, suggestive of an acute exacerbation or secondary infection.

Laboratory results provided further insights into the patient's deteriorating status. Sputum culture grew Pseudomonas aeruginosa, a common pathogen in cystic fibrosis patients, indicating a significant bacterial infection that likely contributed to her increased respiratory symptoms. Blood work revealed elevated white blood cell counts and C-reactive protein levels, both indicative of an inflammatory response and ongoing infection. Arterial blood gas analysis showed a partial pressure of oxygen (PaO2) of 60 mmHg, confirming moderate hypoxemia, necessitating supplemental oxygen therapy.

These findings emphasize the need for an aggressive and targeted approach to manage the infection and prevent further lung damage. The team must now consider modifying the patient's antibiotic regimen, given her penicillin allergy, and explore the potential need for hospital admission to optimize her respiratory support and nutritional management. This situation underscores the complexity of caring for cystic fibrosis patients, requiring careful coordination of multidisciplinary interventions to address both acute and chronic complications effectively.

Section 2

Change in Patient Status:

Following the initiation of supplemental oxygen therapy and the adjustment of her antibiotic regimen to include a combination of inhaled tobramycin and oral ciprofloxacin, the patient began to show some initial signs of improvement. Her respiratory rate decreased from 28 to 22 breaths per minute, and her oxygen saturation levels improved to 92% on 2 liters of oxygen via nasal cannula. Despite these positive changes, the patient's cough remained productive with thick, green sputum, and she reported persistent fatigue and difficulty completing her daily activities.

However, over the next 48 hours, the patient developed new symptoms that suggested further complications. She began experiencing intermittent fevers, with temperatures spiking to 38.5°C, and exhibited increased work of breathing. Upon auscultation, wheezing was now noted bilaterally, accompanied by diminished breath sounds in the right middle lobe, consistent with the infiltrates seen on the CT scan. Repeat blood work showed a further increase in white blood cell count to 15,000/mm³ and a C-reactive protein level that had risen to 150 mg/L, indicating a potentially worsening infection or inflammatory process.

Given these developments, the healthcare team must reconsider the current treatment plan. The possibility of antibiotic resistance, given the persistence of Pseudomonas aeruginosa, needs to be evaluated, and additional supportive measures, such as chest physiotherapy and potential hospitalization for more intensive monitoring and treatment, should be discussed. The patient's nutritional status is also a concern, with her recent weight loss and decreased appetite potentially exacerbating her overall condition. These factors necessitate a comprehensive reassessment of her management plan to prevent further decline and support recovery.

Section 3

The healthcare team decides to conduct a comprehensive assessment to determine the cause of the patient's deteriorating condition. During this assessment, the patient continues to exhibit increased work of breathing, with respirations now at 30 breaths per minute and oxygen saturation intermittently dropping to 89% on 2 liters of oxygen. She reports increased chest tightness and a sensation of not being able to "catch her breath." On physical examination, the patient's skin appears pallid, and she has developed mild peripheral cyanosis. Auscultation reveals persistent wheezing with coarse crackles in the right lower lobe, suggesting possible mucus plugging or atelectasis.

In response to these findings, further diagnostic tests are ordered to assess the underlying issues. A repeat chest X-ray reveals new areas of consolidation in the right middle and lower lobes, consistent with worsening pneumonia. Sputum cultures are obtained to reassess for resistant strains of Pseudomonas aeruginosa or other potential pathogens, while blood cultures are taken to rule out bacteremia. Additionally, given her nutritional concerns, a comprehensive metabolic panel indicates hypoalbuminemia, suggesting malnutrition, and electrolyte imbalances are noted with a mild hyponatremia.

The healthcare team considers intensifying the patient's treatment plan. With these new diagnostic results, there is a strong suspicion of antibiotic resistance. A consultation with an infectious disease specialist is requested to optimize the antibiotic regimen, possibly including intravenous options. Chest physiotherapy is increased to enhance mucus clearance, and nutritional support is initiated with high-calorie supplements to combat malnutrition. The team discusses the possibility of hospital admission for closer monitoring and to provide the intensive respiratory support the patient may require. These steps are crucial to prevent further deterioration and to stabilize the patient’s condition, ensuring a comprehensive approach to managing her complex needs.

Section 4

As the healthcare team proceeds with the intensified treatment plan, the patient is admitted to the hospital for closer observation and management of her respiratory status. Despite increased chest physiotherapy and adjustments in her antibiotic regimen, her respiratory distress persists. Her respiratory rate has escalated to 34 breaths per minute, and her oxygen saturation remains precarious, frequently dipping to 87% even with 3 liters of supplemental oxygen. Arterial blood gases reveal a worsening hypoxemia with a PaO2 of 55 mmHg and an elevated PaCO2 of 52 mmHg, indicating acute on chronic respiratory failure. The patient's heart rate has increased to 115 beats per minute, suggesting compensatory tachycardia, while her blood pressure remains stable.

The infectious disease specialist recommends a broad-spectrum intravenous antibiotic, targeting resistant Pseudomonas aeruginosa identified in the sputum culture. However, the patient's condition does not significantly improve, raising concerns about potential complications such as an evolving pulmonary exacerbation or progression to respiratory failure. The healthcare team decides to escalate respiratory support with the initiation of non-invasive positive pressure ventilation to enhance oxygenation and reduce the work of breathing. Additionally, her nutritional support is intensified with enteral feeding to address her hypoalbuminemia and promote healing and recovery.

Despite these interventions, the patient develops new complications. She begins to experience episodes of confusion and disorientation, likely secondary to hypoxemia and hypercapnia. Neurological assessment reveals a mild tremor and asterixis, suggesting carbon dioxide retention. These signs prompt further investigation into her neurologic status and metabolic derangements. The clinical team collaborates to reassess her treatment strategy, considering the possibility of mechanical ventilation if her respiratory status continues to decline. The focus remains on stabilizing her condition, preventing further complications, and preparing for potential long-term management strategies to improve her quality of life.

Section 5

As the clinical team closely monitors the patient's evolving condition, new diagnostic results provide further insights into her status. A repeat chest X-ray reveals increased bilateral infiltrates, consistent with worsening pulmonary consolidation, suggesting a more severe exacerbation of cystic fibrosis or the development of bronchiectasis. These findings align with new laboratory results indicating a significant leukocytosis, with a white blood cell count climbing to 18,000/mm³, suggestive of a heightened inflammatory response. Additionally, her serum lactate levels have increased to 3.5 mmol/L, raising concerns about potential tissue hypoxia and the risk of sepsis.

In light of these developments, the team re-evaluates her antimicrobial therapy, considering the addition of an aminoglycoside to enhance coverage against the resistant Pseudomonas strain. Concurrently, her oxygenation strategy is reassessed, with a trial of high-flow nasal cannula (HFNC) therapy being initiated to improve oxygen delivery and reduce carbon dioxide retention. This change aims to stabilize her gas exchange and alleviate the symptoms of confusion and disorientation linked to hypercapnia.

The patient's nutritional status remains a critical focus, and her enteral feeding regimen is optimized by incorporating a high-protein, high-calorie formula tailored to meet her increased metabolic demands. As these interventions are implemented, the healthcare team remains vigilant, closely monitoring her response to determine the effectiveness of these strategies and to make timely adjustments. The goal is to prevent further deterioration and to prepare for a potential escalation to mechanical ventilation if her respiratory distress does not improve, while also addressing her long-term management needs to enhance her quality of life.